Compare Nippon Chemiphar Co., Ltd. with Similar Stocks
Dashboard
1
Poor Management Efficiency with a low ROCE of 1.68%
- The company has been able to generate a Return on Capital Employed (avg) of 1.68% signifying low profitability per unit of total capital (equity and debt)
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.89
3
Poor long term growth as Net Sales has grown by an annual rate of 0.90% and Operating profit at 18.19% over the last 5 years
4
The company has declared Negative results for the last 3 consecutive quarters
Stock DNA
Pharmaceuticals & Biotechnology
JPY 6,627 Million (Micro Cap)
12.00
NA
0.00%
0.50
3.28%
0.34
Revenue and Profits:
Net Sales:
8,833 Million
(Quarterly Results - Mar 2026)
Net Profit:
-88 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.3%
0%
-8.3%
6 Months
-0.95%
0%
-0.95%
1 Year
6.38%
0%
6.38%
2 Years
-1.45%
0%
-1.45%
3 Years
-17.43%
0%
-17.43%
4 Years
-17.65%
0%
-17.65%
5 Years
-34.23%
0%
-34.23%
Nippon Chemiphar Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.90%
EBIT Growth (5y)
18.19%
EBIT to Interest (avg)
1.89
Debt to EBITDA (avg)
4.02
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
0.88
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
61.36%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.68%
ROE (avg)
2.50%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.39
EV to EBIT
37.37
EV to EBITDA
8.75
EV to Capital Employed
0.59
EV to Sales
0.53
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
1.59%
ROE (Latest)
3.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
8,833.00
8,325.00
6.10%
Operating Profit (PBDIT) excl Other Income
391.00
478.00
-18.20%
Interest
56.00
57.00
-1.75%
Exceptional Items
-163.00
0.00
Consolidate Net Profit
-88.00
123.00
-171.54%
Operating Profit Margin (Excl OI)
-3.20%
10.10%
-1.33%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 6.10% vs 8.34% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -171.54% vs 292.19% in Dec 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
33,090.00
32,570.00
1.60%
Operating Profit (PBDIT) excl Other Income
1,739.00
1,984.00
-12.35%
Interest
225.00
198.00
13.64%
Exceptional Items
-163.00
-342.00
52.34%
Consolidate Net Profit
198.00
294.00
-32.65%
Operating Profit Margin (Excl OI)
5.40%
18.60%
-1.32%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 1.60% vs 5.93% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is -32.65% vs 263.33% in Mar 2025
About Nippon Chemiphar Co., Ltd. 
Nippon Chemiphar Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






